RetinAI and FVS’ retinopathy screening algorithm gains CE-MDR certification
LuxIA, an AI algorithm co-developed by RetinAI US and FVS, has achieved CE-MDR certification for diabetic retinopathy (DR) screening. The post RetinAI and FVS’ retinopathy screening algorithm gains CE-MDR certification appeared first on Medical Device Network.

The post RetinAI and FVS’ retinopathy screening algorithm gains CE-MDR certification appeared first on Medical Device Network.